Literature DB >> 25695884

MicroRNA-93 promotes ovarian granulosa cells proliferation through targeting CDKN1A in polycystic ovarian syndrome.

Linlin Jiang1, Jia Huang, Lin Li, Yaxiao Chen, Xiaoli Chen, Xiaomiao Zhao, Dongzi Yang.   

Abstract

CONTEXT: MicroRNAs (miRNAs) are small, noncoding RNAs that negatively regulate gene expression post-transcriptionally. Whether differently expressed miRNAs contribute to promoting granulosa cell proliferation in polycystic ovarian syndrome disease (PCOS) remains unknown.
OBJECTIVE: We explored whether certain miRNAs are involved in the ovarian dysfunction of PCOS and the mechanism of increased granulosa cells proliferation. Patients and Cells: miRNA expression was analyzed in excised ovarian cortexes from 16 women with PCOS and 8 non-PCOS. An immortalized human granulosa (KGN) cell was used for the mechanism study. MAIN OUTCOME MEASURES: Expressions of miRNAs in ovarian cortexes were measured using qRT-PCR and KGN granulosa cells were cultured for proliferation assays after overexpression or inhibition of miR-93 or after insulin treatment. Bioinformatics were used to identify the potential miRNA targets. Protein expression analysis, luciferase assays, and rescue assays were used to confirm the substrate of miR-93.
RESULTS: MiR-93 expression was higher in PCOS ovarian cortex and its identified target, CDKN1A, was downregulated. MiR-93 overexpression promoted cell proliferation and G1 to S transition. Knocking down CDKN1A promoted cell growth and cell cycle progression in granulosa cells, and CDKN1A re-introduction reversed the promotional role of miR-93. High concentrations of insulin induced upregulation of miR-93, stimulated KGN cells proliferation and reduced CDKN1A expression.
CONCLUSIONS: miR-93 was increased in PCOS granulosa cells and targeted CDKN1A to promote proliferation and cell cycle progression. Insulin could upregulate the expression of miR-93 and stimulate cell proliferation. This might provide a new insight into the dysfunction of granulosa cells in PCOS.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25695884      PMCID: PMC4422895          DOI: 10.1210/jc.2014-3827

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  39 in total

Review 1.  Development of polycystic ovary syndrome: involvement of genetic and environmental factors.

Authors:  Stephen Franks; Mark I McCarthy; Kate Hardy
Journal:  Int J Androl       Date:  2005-12-22

2.  Effect of insulin on the proliferation of and progesterone production by buffalo granulosa cells in vitro.

Authors:  S Bhushan; P Palta; N Bansal; V Sharma; R S Manik
Journal:  Vet Rec       Date:  2005-12-03       Impact factor: 2.695

3.  Abnormal glucose tolerance in Chinese women with polycystic ovary syndrome.

Authors:  Xiaoli Chen; Dongzi Yang; Lin Li; Shuying Feng; Liangan Wang
Journal:  Hum Reprod       Date:  2006-05-09       Impact factor: 6.918

4.  MiR-135a functions as a tumor suppressor in epithelial ovarian cancer and regulates HOXA10 expression.

Authors:  Weiwei Tang; Yi Jiang; Xiaoxin Mu; Lei Xu; Wenjun Cheng; Xinru Wang
Journal:  Cell Signal       Date:  2014-03-06       Impact factor: 4.315

5.  MiR-506 suppresses proliferation and induces senescence by directly targeting the CDK4/6-FOXM1 axis in ovarian cancer.

Authors:  Guoyan Liu; Yan Sun; Ping Ji; Xia Li; David Cogdell; Da Yang; Brittany C Parker Kerrigan; Ilya Shmulevich; Kexin Chen; Anil K Sood; Fengxia Xue; Wei Zhang
Journal:  J Pathol       Date:  2014-05-21       Impact factor: 7.996

6.  A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors.

Authors:  P Mathijs Voorhoeve; Carlos le Sage; Mariette Schrier; Ad J M Gillis; Hans Stoop; Remco Nagel; Ying-Poi Liu; Josyanne van Duijse; Jarno Drost; Alexander Griekspoor; Eitan Zlotorynski; Norikazu Yabuta; Gabriella De Vita; Hiroshi Nojima; Leendert H J Looijenga; Reuven Agami
Journal:  Cell       Date:  2006-03-24       Impact factor: 41.582

7.  The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation.

Authors:  Jian-Fu Chen; Elizabeth M Mandel; J Michael Thomson; Qiulian Wu; Thomas E Callis; Scott M Hammond; Frank L Conlon; Da-Zhi Wang
Journal:  Nat Genet       Date:  2005-12-25       Impact factor: 38.330

8.  Androgen excess in women: experience with over 1000 consecutive patients.

Authors:  R Azziz; L A Sanchez; E S Knochenhauer; C Moran; J Lazenby; K C Stephens; K Taylor; L R Boots
Journal:  J Clin Endocrinol Metab       Date:  2004-02       Impact factor: 5.958

9.  Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome.

Authors: 
Journal:  Fertil Steril       Date:  2004-01       Impact factor: 7.329

10.  The expression of cyclin-dependent kinase inhibitors p15, p16, p21, and p27 during ovarian follicle growth initiation in the mouse.

Authors:  Aykut Bayrak; Kutluk Oktay
Journal:  Reprod Biol Endocrinol       Date:  2003-05-07       Impact factor: 5.211

View more
  42 in total

1.  Identification of several circulating microRNAs from a genome-wide circulating microRNA expression profile as potential biomarkers for impaired glucose metabolism in polycystic ovarian syndrome.

Authors:  Linlin Jiang; Jia Huang; Yaxiao Chen; Yabo Yang; Ruiqi Li; Yu Li; Xiaoli Chen; Dongzi Yang
Journal:  Endocrine       Date:  2016-02-09       Impact factor: 3.633

Review 2.  Emerging roles for noncoding RNAs in female sex steroids and reproductive disease.

Authors:  Runju Zhang; Victoria Wesevich; Zhaojuan Chen; Dan Zhang; Amanda N Kallen
Journal:  Mol Cell Endocrinol       Date:  2020-07-12       Impact factor: 4.102

3.  miRNA Profiling Reveals miRNA-130b-3p Mediates DENND1A Variant 2 Expression and Androgen Biosynthesis.

Authors:  Jan M McAllister; Angela X Han; Bhavi P Modi; Maria E Teves; Grace R Mavodza; Zachary L Anderson; Tsaiwei Shen; Lane K Christenson; Kellie J Archer; Jerome F Strauss
Journal:  Endocrinology       Date:  2019-08-01       Impact factor: 4.736

4.  Plasma level of miR-93 is associated with higher risk to develop type 2 diabetic retinopathy.

Authors:  Hui-Ling Zou; Yan Wang; Qiang Gang; Ying Zhang; Yu Sun
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-04-05       Impact factor: 3.117

5.  MicroRNA-93 promotes cell proliferation by directly targeting P21 in osteosarcoma cells.

Authors:  Yu He; Bo Yu
Journal:  Exp Ther Med       Date:  2017-03-08       Impact factor: 2.447

Review 6.  The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited.

Authors:  Robert L Rosenfield; David A Ehrmann
Journal:  Endocr Rev       Date:  2016-07-26       Impact factor: 19.871

7.  miR-424 suppresses proliferation and promotes apoptosis of human ovarian granulosa cells by targeting Apelin and APJ expression.

Authors:  Jing Du; Xiufeng Lin; Riran Wu; Zixuan Gao; Yan Du; Yuechan Liao; Song Quan
Journal:  Am J Transl Res       Date:  2020-07-15       Impact factor: 4.060

8.  The HMGA2-IMP2 Pathway Promotes Granulosa Cell Proliferation in Polycystic Ovary Syndrome.

Authors:  Miao Li; Han Zhao; Shi-Gang Zhao; Dai-Min Wei; Yue-Ran Zhao; Tao Huang; Tahir Muhammad; Lei Yan; Fei Gao; Lei Li; Gang Lu; Wai-Yee Chan; Peter C K Leung; Andrea Dunaif; Hong-Bin Liu; Zi-Jiang Chen
Journal:  J Clin Endocrinol Metab       Date:  2019-04-01       Impact factor: 5.958

9.  Genome-wide screening differential long non-coding RNAs expression profiles discloses its roles involved in OHSS development.

Authors:  Haiyan Lin; Yu Li; Weijie Xing; Qi Qiu; Wenjun Wang; Qingxue Zhang
Journal:  J Assist Reprod Genet       Date:  2018-06-04       Impact factor: 3.412

Review 10.  The role of miRNAs in polycystic ovary syndrome with insulin resistance.

Authors:  Yingliu Luo; Chenchen Cui; Xiao Han; Qian Wang; Cuilian Zhang
Journal:  J Assist Reprod Genet       Date:  2021-01-06       Impact factor: 3.412

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.